Trials / Conditions / T-cell Large Granular Lymphocytic Leukemia
T-cell Large Granular Lymphocytic Leukemia
5 registered clinical trials studyying T-cell Large Granular Lymphocytic Leukemia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Registry for People With T-cell Lymphoma NCT05978141 | Memorial Sloan Kettering Cancer Center | — |
| Active Not Recruiting | ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL) NCT05532722 | Abcuro, Inc. | Phase 1 / Phase 2 |
| Unknown | CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma NCT02742727 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Phase 1 / Phase 2 |
| Terminated | Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia NCT00278265 | German CLL Study Group | Phase 2 |
| Completed | Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia NCT00076180 | National Cancer Institute (NCI) | Phase 1 |